Insider Trading & Ownership of Highpoint Pharmaceuticals LLC

Location: Lewes, DE
Summary: The estimated value of insider holdings of Highpoint Pharmaceuticals LLC is at least $489,028 dollars as of 11 Jan 2022. Highpoint Pharmaceuticals LLC is the 10%+ Owner of Hillstream BioPharma Inc. and owns shares of Tharimmune, Inc. (THAR) stock worth about $489K.
Signature: /s/ Sireesh Appajosyula
All Insider Reports: All Insider Reports

Notify me when Highpoint Pharmaceuticals LLC files a new Insider Trading report.

Ownership of Highpoint Pharmaceuticals LLC

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
THAR	Tharimmune, Inc.	10%+ Owner	$489,028			11 Jan 2022